Concepedia

Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies

Anna Patrikidou, Isabelle Sinapi, Hélène Regnault, Florence Fayard, Mohamed Bouattour, Sandrine Faivre, David Malka, Michel Ducreux, Valérie Boige

Investigational New Drugs · 2014 · 31 citations · 21 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerMalignant NeoplasmsToxicity ManagementAngiogenic BiomarkersGemcitabine-based TherapyHepatocellular Carcinoma TreatmentLiver Tumor TherapyOxaliplatin-based TherapyPlatinum-based CombinationsPlatinum-based Regimens

References

21

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

Sorafenib in Advanced Hepatocellular Carcinoma

재연 정 · 2008 · 5.6K citations

Medicine, Oncology, Pharmacology +12